Generics and the specific features of their regulation
The article discusses the factors that influence the efficacy and safety of generic drugs, including regular generics, biosimilars, and generic nonbiological complex drugs. It emphasizes the importance of adequate regulatory requirements to provide a comparable therapeutic efficacy and a comparable...
Main Authors: | E. A. Ushkalova, S. K. Zyryanov, A. V. Ushkalova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2016-11-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/653 |
Similar Items
-
Generics and biosimilars in oncology
by: I. A. Gopienko, et al.
Published: (2020-04-01) -
Economic challenges of oncological diseases’ pharmacotherapy
by: E. A. Ushkalova, et al.
Published: (2020-04-01) -
Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
by: E. A. Ushkalova, et al.
Published: (2018-07-01) -
Generic and biosimilar medicines: quid?
by: Steven Simoens
Published: (2012-12-01) -
From generic to biosimilar drugs: why take an innovative pace?
by: Fereshteh Barei, et al.
Published: (2012-12-01)